Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Early Initiation of Cyclosporin and Mycophenolate in Haplo Transplantation with Post Transplant Cyclophosphamide; Significantly Decreases Cytokine Release Syndrome and Abrogates Its Severity. a Study of 110 Patients with Leukemia Transplanted with Peripheral Blood Stem Cells

Amado J Karduss, Guillermo Herrera, Angela Maria Trujillo, Angelica M Cardona, Marcos Arango, Giovanny Ruiz, Rosendo Perez

Blood (2023) 142 (Supplement 1): 1044.

https://doi.org/10.1182/blood-2023-185005

Published: 2023

Journal Articles

Cyclophosphamide, Etoposide, and Intermediate-Dose of Carboplatin; An Efficient Preparative Regimen for Autologous Transplantation for Patients with Lymphoma, a Good Alternative to Those Based on Carmustine. Experience with 108 Patients

Giovanni Ruiz, Amado J Karduss, Angela Maria Trujillo, Rosendo Perez, Angelica Cardona, Lina Callejas

Blood (2021) 138 (Supplement 1): 2914.

https://doi.org/10.1182/blood-2021-149816

Published: 2021

Journal Articles

Long Term Follow up of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Children and Teenagers < 18 Years Old with High-Risk Acute Leukemia. Very Good Results in CR1 and CR2 Patients but Unexpected High Incidence of Severe Acute Graft Versus Host Disease in Children < 10 Years

Angela Maria Trujillo, MD, Amado J Karduss, MD, Gloria Suarez, MD, Rosendo Perez, MD, Giovanni Ruiz, MD, Angelica Cardona, tech, Jimenez Alejo, MD, Monica Ramirez, MD, Jose Betancur, MD, Pedro Reyes, MD, Luis R Gomez, MD

Blood (2017) 130 (Supplement 1): 4563.

https://doi.org/10.1182/blood.V130.Suppl_1.4563.4563

Published: 2017

Journal Articles

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic Activity

Amado J Karduss-Urueta, MD, Rosendo Perez, MD, Gloria Suarez, Alejo Jimenez, MD, Giovanni Ruiz, MD, Angela Maria Trujillo, MD, Monica Ramirez, Jose Betancur, MD, Pedro Reyes, MD, Luis Rodolfo Gomez, MD, Angelica Cardona

Blood (2016) 128 (22): 2192.

https://doi.org/10.1182/blood.V128.22.2192.2192

Published: 2016

Journal Articles

Intensification of the Regimen Fludarabine Melphalan with the Addition of 400 Cgy of Total Body Irradiation in Allogeneic Stem Cell Transplantation. It Is Feasible, Has a Good Anti-Leukemic Effect and a Low Toxicity

Amado J Karduss-Urueta, MD, Giovanni Ruiz, MD, Rosendo Perez, Alejo Jimenez, MD, Angelica Cardona, Tech, Gloria Suarez, MD, Luis R Gomez, MD, Pedro Reyes, MD

Blood (2015) 126 (23): 1916.

https://doi.org/10.1182/blood.V126.23.1916.1916

Published: 2015

Journal Articles

Cell-Freezing Devices Are Not Strictly Needed to Start an Autologous Hematopoietic Transplantation Program: Non-Cryopreserved Peripheral Blood Stem Cells Can be Used to Restore Hematopoiesis after High Dose Chemotherapy: A Multicenter Experience in 268 Autografts in Patients with Multiple Myeloma or Lymphoma. Study on Behalf of the Latin-American Bone Marrow Transplantation Group (LABMT)

Amado J Karduss-Urueta, MD, Guillermo J. Ruiz-Arguelles, MD FRCP (Glasg), MACP, Rosendo Perez, MD, Guillermo J Ruiz-Delgado, MD, Angelica Maria Cardona, Tech, Nancy Labastida-Mercado, MD, Luis R Gomez, MD, Samantha Galindo-Becerra, MD, Pedro Reyes, MD, Juan Alejo Jimenez, MD

Blood (2014) 124 (21): 849.

https://doi.org/10.1182/blood.V124.21.849.849

Published: 2014

NARROW

Early Initiation of Cyclosporin and Mycophenolate in Haplo Transplantation with Post Transplant Cyclophosphamide; Significantly Decreases Cytokine Release Syndrome and Abrogates Its Severity. a Study of 110 Patients with Leukemia Transplanted with Peripheral Blood Stem Cells

Cyclophosphamide, Etoposide, and Intermediate-Dose of Carboplatin; An Efficient Preparative Regimen for Autologous Transplantation for Patients with Lymphoma, a Good Alternative to Those Based on Carmustine. Experience with 108 Patients

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic Activity

Intensification of the Regimen Fludarabine Melphalan with the Addition of 400 Cgy of Total Body Irradiation in Allogeneic Stem Cell Transplantation. It Is Feasible, Has a Good Anti-Leukemic Effect and a Low Toxicity

Email alerts

ASH Publications

American Society of Hematology

Early Initiation of Cyclosporin and Mycophenolate in Haplo Transplantation with Post Transplant Cyclophosphamide; Significantly Decreases Cytokine Release Syndrome and Abrogates Its Severity. a Study of 110 Patients with Leukemia Transplanted with Peripheral Blood Stem Cells

Cyclophosphamide, Etoposide, and Intermediate-Dose of Carboplatin; An Efficient Preparative Regimen for Autologous Transplantation for Patients with Lymphoma, a Good Alternative to Those Based on Carmustine. Experience with 108 Patients

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic Activity

Intensification of the Regimen Fludarabine Melphalan with the Addition of 400 Cgy of Total Body Irradiation in Allogeneic Stem Cell Transplantation. It Is Feasible, Has a Good Anti-Leukemic Effect and a Low Toxicity

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only